Watch Ticker

TNF Pharmaceuticals, Inc. Common Stock

Go to TNF Pharmaceuticals, Inc. Common Stock Website

$0.10

0.00 (-3.90%)

Live

Previous Close

$0.105

Day Range

$0.098 - $0.1071

Previous Day Range

$0.0999 - $0.1115

Market Cap

$1.5 million USD

Day Vol.

13.3 million

Previous Day Vol.

27.0 million

Currency

USD

Primary Exchange

None

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms, Isomyosamine and Supera-CBD. Isomyosamine is a small molecule that ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The sarcopenia market remains largely untapped, with significant unmet medical needs and no approved drug therapies. However, pharmaceutical interest is rising, particularly around muscle-enhancing agents and anti-inflammatory pathways. Regulatory bodies are beginning to recognize sarcopenia as a distinct clinical condition, which may streamline future drug approvals.

Related tickers: BPTSY, TNFA, LPCN.

Read Full Article

Trending Tickers

Please sign in to view